Effcacy of radical cystectomy plus adjuvant intraarterial chemotherapy with gemcitabine and cisplatin on locally advanced bladder cancer

Chinese Medical Journal

Volumn 127, Issue 7, 2014, Pages 1249-1254

  Jiang, Li Juan ^a   Zhang, Zhi Ling ^a   Dong, Pei ^a   Li, Yong Hong ^a   Yao, Kai ^a   Liu, Zhuo Wei ^a   Han, Hui ^a   Qin, Zike ^a   Yao, Min ^b   Zhou, Fang Jian ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant chemotherapy; Adjuvant intraarterial chemotherapy; Bladder cancer; Radical cystectomy

Indexed keywords

CISPLATIN; CREATININE; ELECTROLYTE; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; NITROGEN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ANGIOGRAPHIC CATHETER; ARTICLE; BLADDER CANCER; BONE MARROW SUPPRESSION; CANCER INCIDENCE; CONTROLLED STUDY; CYSTECTOMY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE SPECIFIC SURVIVAL; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RETROSPECTIVE STUDY; THORAX RADIOGRAPHY; VERY ELDERLY; ANALOGS AND DERIVATIVES; MIDDLE AGED; PROCEDURES; URINARY BLADDER NEOPLASMS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CISPLATIN; CYSTECTOMY; DEOXYCYTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84897949056     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20131612     Document Type: Article

References (30)

1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009; 27: 289-293.
2. Zhou FJ, Yu SL, Li YH, Liu ZW, Xiong YH, Wu PH, et al. Intra-arterial chemotherapy with gemcitabine and cisplatin for patients with recurrence of transitional cell carcinoma confined to the pelvis. J Chemothe 2009; 21: 91-97.
3. Ghoneim M, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, et al. Radical cystectomy for carcinoma of the bladder: 2 720 consecutive cases 5 years later. J Urol 2008; 180: 121-127.
4. Gschwend JE, Dahm P, Fair WR. Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 2002; 41: 440-448.
5. Zhang ZL, Xiong YH, Li YH, Hou GL, Liu ZW, Zhou FJ, et al. Reassessment of the predictive role of perivesical fat invasion in invasive bladder cancer prognosis in 151 Chinese patients. Chin Med J 2011; 124: 2915-2919.
6. Tilki D, Svatek RS, Karakiewicz PI, Novara G, Seitz M, Son-pavde G, et al. pT3 Substaging is a prognostic indicator for lymph node negative urothelial carcinoma of the bladder. J Urol 2010; 184: 470-474.
7. Kigawa J, Minagawa Y, Ishihara H, Itamochi H, Kanamori Y, Terakawa N. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495-500.
8. Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, et al. Adjuvant polychemotherapy of nonorgan-confned bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol 1995; 153: 47-52.
9. Studer UE, Bacchi M, Biedermann C, Jaeger P, Kraft R, Maz-zucchelli L, et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 1994; 152: 81-84.
10. Skinner DG, Daniels JR, Russell CA, Lieskovsky G, Boyd SD, Krailo M, et al. Adjuvant chemotherapy following cystectomy benefits patients with deeply invasive bladder cancer. Semin Urol 1990; 8: 279-284.
11. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-199; discussion 199-201.
12. Guidelines on Bladder Cancer EUA 2011:Guidelines on bladder cancer muscle-invasive and metastatic. Eur Assoc Urol Online Guide 2011; 59: 1009-1018.
13. David KA, Milowsky MI, Ritchey J, Carroll PR, Nanus DM. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-454.
14. NCCN Practice Guidelines in oncology-V.1. 2010: Bladder cancer. (Accessed at http://www.nccn.org/professionals/physician_gls/f_guidelines.asp)
15. Vonder Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, et al. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000; 17: 3068-3077.
16. Shimizu Y, Hasumi K, Miura S, Okudaira Y, Masubuchi K. Intraarterial infusion of oncostasis in patients with recurrent cervical cancer (in Japanese). Nihon Sanka Fujinka Gakkai Zasshi 1988; 40: 511-514.
17. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1 054 patients. J Clin Oncol 2001; 19: 666-675.
18. Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989; 64: 2448-2458.
19. Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, et al. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 1988; 139: 461-469.
20. Loehrer PJ Sr, Einhorn LH, Elson PJ, Crawford ED, Kuebler P, Tannock I, et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol 1992; 10: 1066-1073.
21. Saxman SB, Propert KJ, Einhorn LH, Crawford ED, Tannock I, Raghavan D, et al. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothe-lial carcinoma: a cooperative group study. J Clin Oncol 1997; 15: 2564-2569.
22. Cognetti F, Ruggeri EM, Felici A, Gallucci M, Muto G, Pollera CF, et al. Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, mul-ticenter, randomized phase III trial. Ann Oncol 2011; 23: 695-700.
23. Mokarim A, Uetani M, Sakamoto I, Hayashi N, Nomata K, Ohtani H. Transarterial infusion of cisplatin and doxorubicin in bladder cancer. Acta Oncol 1997; 36: 175-181.
24. Tanaka H, Kondo E, Kawato H, Kikukawa T, Toyoda N. Aortitis during intraarterial chemotherapy for cervical cancer. Int J Clin Oncol 2002; 7: 62-65.
25. Shimizu Y, Hasumi K, Miura S, Okudaira Y, Masubuchi K. In-traarterial infusion of oncostasis in patients with recurrent cervical cancer. Nihon Sanka Fujinka Gakkai Zasshi 1988; 40: 511-514.
26. Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, et al. Clinical pharmacology of intraarterial cis-diamminedichoroplatinum (II). Cancer Res 1983; 43: 917-920.
27. Miyanaga N, Akaza H, Hinotsu S, Joraku A, Oikawa T, Sekido N, et al. Background variables for the patients with invasive bladder cancer suitable for bladder-preserving therapy. Jpn J Clin Oncol 2007; 37: 852-857.
28. Daniels JR, Sternlicht M, Daniels AM. Collagen chemoemboli-zation: pharmacokinetics and tissue tolerance of cisdiamminedi-choroplatinum (II) in porcine liver and rabbit kidney. Cancer Res 1988; 48: 2446-2450.
29. Hoshi S, Mao H, Takahashi T, Suzuki K, Nose M, Orikasa S. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer. Int J Urol 1997; 4: 493-499.
30. Mokarim A, Uetani M, Hayashi N, Sakamoto I, Minami K, Ogawa Y, et al. Combined intraarterial chemotherapy and radiotherapy in the treatment of bladder carcinoma. Cancer 1997 80: 1776-1785.